220 related articles for article (PubMed ID: 32256496)
1. Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV.
Martinez-Navio JM; Fuchs SP; Mendes DE; Rakasz EG; Gao G; Lifson JD; Desrosiers RC
Front Immunol; 2020; 11():449. PubMed ID: 32256496
[TBL] [Abstract][Full Text] [Related]
2. AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity.
Fuchs SP; Martinez-Navio JM; Piatak M; Lifson JD; Gao G; Desrosiers RC
PLoS Pathog; 2015 Aug; 11(8):e1005090. PubMed ID: 26248318
[TBL] [Abstract][Full Text] [Related]
3. Host Anti-antibody Responses Following Adeno-associated Virus-mediated Delivery of Antibodies Against HIV and SIV in Rhesus Monkeys.
Martinez-Navio JM; Fuchs SP; Pedreño-López S; Rakasz EG; Gao G; Desrosiers RC
Mol Ther; 2016 Feb; 24(1):76-86. PubMed ID: 26444083
[TBL] [Abstract][Full Text] [Related]
4. Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
Hessell AJ; Shapiro MB; Powell R; Malherbe DC; McBurney SP; Pandey S; Cheever T; Sutton WF; Kahl C; Park B; Zolla-Pazner S; Haigwood NL
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514914
[TBL] [Abstract][Full Text] [Related]
5. Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys.
Pan E; Feng F; Li P; Yang Q; Ma X; Wu C; Zhao J; Yan H; Chen R; Chen L; Sun C
Front Immunol; 2018; 9():2415. PubMed ID: 30405615
[TBL] [Abstract][Full Text] [Related]
6. AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges.
Gardner MR; Fellinger CH; Kattenhorn LM; Davis-Gardner ME; Weber JA; Alfant B; Zhou AS; Prasad NR; Kondur HR; Newton WA; Weisgrau KL; Rakasz EG; Lifson JD; Gao G; Schultz-Darken N; Farzan M
Sci Transl Med; 2019 Jul; 11(502):. PubMed ID: 31341061
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.
Castro IM; Ricciardi MJ; Gonzalez-Nieto L; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI; Martins MA
J Virol; 2021 Jun; 95(14):e0033021. PubMed ID: 33910957
[TBL] [Abstract][Full Text] [Related]
8. Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus.
Bilello JP; Manrique JM; Shin YC; Lauer W; Li W; Lifson JD; Mansfield KG; Johnson RP; Desrosiers RC
J Virol; 2011 Dec; 85(23):12708-20. PubMed ID: 21900170
[TBL] [Abstract][Full Text] [Related]
9. Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression.
Martinez-Navio JM; Fuchs SP; Pantry SN; Lauer WA; Duggan NN; Keele BF; Rakasz EG; Gao G; Lifson JD; Desrosiers RC
Immunity; 2019 Mar; 50(3):567-575.e5. PubMed ID: 30850342
[TBL] [Abstract][Full Text] [Related]
10. A Mucosal Adenovirus Prime/Systemic Envelope Boost Vaccine Regimen Elicits Responses in Cervicovaginal and Alveolar Macrophages of Rhesus Macaques Associated With Delayed SIV Acquisition and B Cell Help.
Hunegnaw R; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Ko EJ; Hogge CJ; Hoang T; Robert-Guroff M
Front Immunol; 2020; 11():571804. PubMed ID: 33117363
[TBL] [Abstract][Full Text] [Related]
11. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
[TBL] [Abstract][Full Text] [Related]
12. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
[TBL] [Abstract][Full Text] [Related]
13. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
14. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
16. Use of a gamma-2 herpesvirus as a vector to deliver antibodies to rhesus monkeys.
Bischof GF; Shin YC; Fuchs SP; Martinez-Navio JM; Lauer WA; Rakasz EG; Desrosiers RC
Gene Ther; 2017 Aug; 24(8):487-492. PubMed ID: 28660888
[TBL] [Abstract][Full Text] [Related]
17. Protection of Newborn Macaques by Plant-Derived HIV Broadly Neutralizing Antibodies: a Model for Passive Immunotherapy during Breastfeeding.
Rosenberg YJ; Jiang X; Cheever T; Coulter FJ; Pandey S; Sack M; Mao L; Urban L; Lees J; Fischer M; Smedley J; Sidener H; Stanton J; Haigwood NL
J Virol; 2021 Aug; 95(18):e0026821. PubMed ID: 34190597
[TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.
Mörner A; Jansson M; Bunnik EM; Schøller J; Vaughan R; Wang Y; Montefiori DC; Otting N; Bontrop R; Bergmeier LA; Singh M; Wyatt RT; Schuitemaker H; Biberfeld G; Thorstensson R; Lehner T
J Virol; 2011 Jul; 85(13):6442-52. PubMed ID: 21490092
[TBL] [Abstract][Full Text] [Related]
19. Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.
Martins MA; Gonzalez-Nieto L; Ricciardi MJ; Bailey VK; Dang CM; Bischof GF; Pedreño-Lopez N; Pauthner MG; Burton DR; Parks CL; Earl P; Moss B; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI
J Virol; 2020 Nov; 94(24):. PubMed ID: 33028714
[TBL] [Abstract][Full Text] [Related]
20. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
